Pfizer-BioNTech vaccine appears effective against mutation in new coronavirus variants, study suggests
Published
Pfizer Inc. and BioNTech's COVID-19 vaccine appeared to work against a key mutation in the highly transmissible new variants of the coronavirus discovered in Britain and South Africa, according to a laboratory study conducted by the U.S. drugmaker.
Full Article